Home/ Stocks/ ASBP

Aspire Biopharma Holdings, Inc. Common Stock

ASBP XNAS

$6.03 +0.06 (+1.01%) ▲ 15-min delayed

Open

$5.88

High

$6.15

Low

$5.88

Volume

22.3K

Market Cap

$7.73M

About Aspire Biopharma Holdings, Inc. Common Stock

Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

Sector: PHARMACEUTICAL PREPARATIONS Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$28.4K	$-3,222,892	$-20.57
FY 2025	$6.2K	$-24,480,848	N/A
Q3 2025	$884	$-1,850,493	$-0.04
Q1 2025	N/A	$-15,941,328	N/A

TickerDaily Coverage

Why Is Aspire Biopharma Holdings, Inc. Common Stock (ASBP) Stock Down 50.4% Today?

Penny Stocks Marcus Rivera · Apr 15, 2026

Aspire Biopharma Holdings (ASBP) stock plummeted 50.4% Wednesday, April 15, 2026, closing at...

View All Coverage →

Get ASBP Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Aspire Biopharma Holdings, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.